Canopy Growth (CGC) Non-Current Debt (2017 - 2026)

Canopy Growth (CGC) reported Non-Current Debt of $158.3 million for Q1 2026, down 24.22% on a YoY basis from $208.9 million in Q1 2025, and down 1.87% sequentially from $161.3 million in Q4 2025.

Canopy Growth (CGC) Non-Current Debt (2017 - 2026) Analysis & Trends

Canopy Growth (CGC) has 10 years of Non-Current Debt data on file, last reported at $158.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Debt fell 24.22% year-over-year to $158.3 million; the trailing twelve-month figure through Mar 2026 stood at $158.3 million (down 24.22% YoY), and the FY2026 full-year result was $158.3 million, down 24.22% from the prior year.
  • Non-Current Debt slipped to $158.3 million in Q1 2026, from $161.3 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $1.2 billion in Q1 2022 to a low of $158.3 million in Q1 2026.
  • A 5-year average of $459.2 million and a median of $382.5 million in 2023 frame the typical range for Non-Current Debt.
  • Peak annual rise in Non-Current Debt reached 5.25% in 2022, while the deepest fall reached 53.4% in 2022.
  • Tracing CGC's Non-Current Debt over 5 years: stood at $552.6 million in 2022, then tumbled by 30.78% to $382.5 million in 2023, then retreated by 17.95% to $313.8 million in 2024, then slumped by 48.59% to $161.3 million in 2025, then dropped by 1.87% to $158.3 million in 2026.
  • Business Quant data shows CGC's Non-Current Debt at $158.3 million in Q1 2026, $161.3 million in Q4 2025, and $164.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 10.34 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 14.02 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 9.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 27.86 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 12.41 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.74 Bn
10 Canopy Growth 197.77 Mn -68.15 Mn - 158.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 158.33 Mn
Dec 31, 2025 161.34 Mn
Sep 30, 2025 164.46 Mn
Jun 30, 2025 208.57 Mn
Mar 31, 2025 208.94 Mn
Dec 31, 2024 313.83 Mn
Sep 30, 2024 304.90 Mn
Jun 30, 2024 408.33 Mn
Mar 31, 2024 366.08 Mn
Dec 31, 2023 382.50 Mn
Sep 30, 2023 470.85 Mn
Jun 30, 2023 589.70 Mn
Mar 31, 2023 554.77 Mn
Dec 31, 2022 552.61 Mn
Sep 30, 2022 791.38 Mn
Jun 30, 2022 991.91 Mn
Mar 31, 2022 1.18 Bn
Dec 31, 2021 1.19 Bn
Sep 30, 2021 1.21 Bn
Jun 30, 2021 1.26 Bn